Wordt geladen...

From Laboratory Studies to Clinical Trials: Temozolomide Use in IDH-Mutant Gliomas

In this review, we discuss the use of the alkylating agent temozolomide (TMZ) in the treatment of IDH-mutant gliomas. We describe the challenges associated with TMZ in clinical (drug resistance and tumor recurrence) and preclinical settings (variabilities associated with in vitro models) in treating...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cells
Hoofdauteurs: Sun, Xueyuan, Turcan, Sevin
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: MDPI 2021
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8157002/
https://ncbi.nlm.nih.gov/pubmed/34067729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells10051225
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!